NO306397B1 - 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater - Google Patents

15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater

Info

Publication number
NO306397B1
NO306397B1 NO961891A NO961891A NO306397B1 NO 306397 B1 NO306397 B1 NO 306397B1 NO 961891 A NO961891 A NO 961891A NO 961891 A NO961891 A NO 961891A NO 306397 B1 NO306397 B1 NO 306397B1
Authority
NO
Norway
Prior art keywords
intermediates
deoxypergualin
analogs
preparation
pharmaceutical preparations
Prior art date
Application number
NO961891A
Other languages
English (en)
Norwegian (no)
Other versions
NO961891D0 (no
NO961891L (no
Inventor
Luc Lebreton
Patrice Renaut
Christine Dumas
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of NO961891D0 publication Critical patent/NO961891D0/no
Publication of NO961891L publication Critical patent/NO961891L/no
Publication of NO306397B1 publication Critical patent/NO306397B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/14Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO961891A 1995-05-17 1996-05-10 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater NO306397B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505862A FR2734263B1 (fr) 1995-05-17 1995-05-17 Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique

Publications (3)

Publication Number Publication Date
NO961891D0 NO961891D0 (no) 1996-05-10
NO961891L NO961891L (no) 1996-11-18
NO306397B1 true NO306397B1 (no) 1999-11-01

Family

ID=9479086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961891A NO306397B1 (no) 1995-05-17 1996-05-10 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater

Country Status (22)

Country Link
US (1) US5733928A (de)
EP (1) EP0743300B1 (de)
JP (1) JP2860778B2 (de)
KR (1) KR960041153A (de)
CN (1) CN1063744C (de)
AT (1) ATE182882T1 (de)
AU (1) AU694342B2 (de)
CA (1) CA2176670C (de)
CZ (1) CZ292373B6 (de)
DE (1) DE69603541T2 (de)
DK (1) DK0743300T3 (de)
ES (1) ES2137634T3 (de)
FR (1) FR2734263B1 (de)
GR (1) GR3031684T3 (de)
HU (1) HUP9601323A3 (de)
NO (1) NO306397B1 (de)
NZ (1) NZ286582A (de)
RU (1) RU2130015C1 (de)
SK (1) SK283372B6 (de)
TW (1) TW354782B (de)
UA (1) UA42798C2 (de)
ZA (1) ZA963775B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843995A (en) * 1997-07-07 1998-12-01 University Of Medicine And Dentistry Of New Jersey Inhibition of HIV-1 replication using oligocarbamate derivatives
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
UA42798C2 (uk) 2001-11-15
EP0743300B1 (de) 1999-08-04
NO961891D0 (no) 1996-05-10
RU2130015C1 (ru) 1999-05-10
ATE182882T1 (de) 1999-08-15
HUP9601323A2 (en) 1997-05-28
GR3031684T3 (en) 2000-02-29
HUP9601323A3 (en) 1998-04-28
SK63696A3 (en) 1996-12-04
CA2176670C (en) 2002-03-26
FR2734263B1 (fr) 1997-06-20
AU5208196A (en) 1996-11-28
JP2860778B2 (ja) 1999-02-24
TW354782B (en) 1999-03-21
NO961891L (no) 1996-11-18
FR2734263A1 (fr) 1996-11-22
DK0743300T3 (da) 2000-01-24
DE69603541D1 (de) 1999-09-09
SK283372B6 (sk) 2003-06-03
DE69603541T2 (de) 2000-04-06
CN1143075A (zh) 1997-02-19
CZ142396A3 (en) 1997-02-12
ZA963775B (en) 1996-11-25
NZ286582A (en) 1998-07-28
JPH0977733A (ja) 1997-03-25
AU694342B2 (en) 1998-07-16
ES2137634T3 (es) 1999-12-16
CN1063744C (zh) 2001-03-28
CA2176670A1 (en) 1996-11-18
EP0743300A1 (de) 1996-11-20
KR960041153A (ko) 1996-12-19
CZ292373B6 (cs) 2003-09-17
HU9601323D0 (en) 1996-07-29
US5733928A (en) 1998-03-31

Similar Documents

Publication Publication Date Title
ATE143598T1 (de) Arzneimittellösung enhaltend derivate von fk506
MX9306831A (es) Nuevos compuestos heterociclicos.
FI914928A0 (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ES553936A0 (es) Un procedimiento para la preparacion de nuevas n-((4-piperidinil)alquil)oxazol y tiazolaminas condensadas biciclicas sustituidas
GB8525913D0 (en) Compounds
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
FI884070A0 (fi) Rytmstoerningar foerhindrande medel.
NO306397B1 (no) 15-deoksyspergualinanaloger, mellomprodukter for deres fremstilling, deres anvendelse samt farmasöytiske preparater
ATE100459T1 (de) Antifungale antibiotika.
DK521685D0 (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
DK160488D0 (da) Aebenzazepinsulfonamid-forbindelser, deres anvendelse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne samt benzazepin-forbindelser, der er nyttige som mellemprodukterae
DK624989D0 (da) Hidtil ukendte forbindelser
DE3666223D1 (en) Anticonvulsant agents
DK0552712T3 (da) 8-(1-aminocycloalkyl)1,3-dialkylxanthinderivater som antagonister for adenosinreceptorer
NO306300B1 (no) 3-alkoksykarbonyltiadiazinoner, farmasöytiske preparater som inneholder minst èn slik forbindelse, og anvendelse av forbindelsene til fremstilling av legemidler
DK158729C (da) N-(3-trifluormethylphenyl)-n'-propargylpiperazin, farmaceutiske praeparater, der indeholder det, dets anvendelse, samt en fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK0417746T3 (da) N-Azabicyclo(3.3.0)octanamider af aromatiske syrer
SE8503054D0 (sv) Catecholcarboxamides
FI873145A0 (fi) Nya tetracykliska indolderivat.
DK0578052T3 (da) Anvendelse af iminoderivater af etianaldehyd til fremstilling af et lægemiddel til behandling af hypertension
SE8506095D0 (sv) New enzyme inhibitor
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees